不同表型肿瘤相关巨噬细胞在肿瘤进展中的作用

郭浩越 毛锐 王冉 朱尔家 陈东来 陈昶

郭浩越, 毛锐, 王冉, 朱尔家, 陈东来, 陈昶. 不同表型肿瘤相关巨噬细胞在肿瘤进展中的作用[J]. 中国肿瘤临床, 2018, 45(9): 482-486. doi: 10.3969/j.issn.1000-8179.2018.09.239
引用本文: 郭浩越, 毛锐, 王冉, 朱尔家, 陈东来, 陈昶. 不同表型肿瘤相关巨噬细胞在肿瘤进展中的作用[J]. 中国肿瘤临床, 2018, 45(9): 482-486. doi: 10.3969/j.issn.1000-8179.2018.09.239
Guo Haoyue, Mao Rui, Wang Ran, Zhu Erjia, Chen Donglai, Chen Chang. Role of different phenotype tumor-associated macrophages in tumor progression[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 45(9): 482-486. doi: 10.3969/j.issn.1000-8179.2018.09.239
Citation: Guo Haoyue, Mao Rui, Wang Ran, Zhu Erjia, Chen Donglai, Chen Chang. Role of different phenotype tumor-associated macrophages in tumor progression[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 45(9): 482-486. doi: 10.3969/j.issn.1000-8179.2018.09.239

不同表型肿瘤相关巨噬细胞在肿瘤进展中的作用

doi: 10.3969/j.issn.1000-8179.2018.09.239
基金项目: 

上海申康医院发展中心临床科技创新项目 SHDC12015116

“上海市领军人才”项目 057

详细信息
    作者简介:

    郭浩越  专业方向为肿瘤微环境及肿瘤基础治疗的研究。E-mail:1553012@tongji.edu.cn

    通讯作者:

    陈昶  chenthoracic@163.com

Role of different phenotype tumor-associated macrophages in tumor progression

More Information
  • 摘要: 随着对肿瘤发生、侵袭和转移过程研究的不断深入,临床发现肿瘤相关巨噬细胞(tumor associated macrophage,TAM)在肿瘤微环境中扮演重要角色。由于经典活化的巨噬细胞(M1)/替代性活化的巨噬细胞(M2)理论过度简化了TAM在肿瘤微环境中的多种作用,目前临床大多根据表面蛋白表达的不同将TAM重新分为CD68+TAM、CD163+TAM、CD204+TAM、CD169+TAM、CCL18+TAM等。各型TAM表达的表面蛋白具有不同类型的配体并调控着不同的信号通路和细胞因子。因此,这些亚型的TAM具有促进或抑制肿瘤的类似作用,但其所牵涉的机制以及带来的临床表现均不相同。本文将就TAM各类表型对各类肿瘤的生长、转移、预后的影响及其临床关联进行综述。

     

  • 表  1  募集、诱导分化TAM及其自身分泌的细胞因子

    表  2  TAM不同表型对肿瘤进展的作用及其机制

  • [1] Coussens LM, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420 (6917):860-867. doi: 10.1038/nature01322
    [2] Ohno S, Ohno Y, Suzuki N, et al. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer[J]. Anticancer Res, 2004, 24(c):3335-3342. http://www.ncbi.nlm.nih.gov/pubmed/15515429
    [3] Owen JL, Mohamadzadeh M. Macrophages and chemokines as mediators of angiogenesis[J]. Front Physiol, 2013, 4(159):1-8. https://www.researchgate.net/profile/Jennifer_Owen2/publication/248706542_Macrophages_and_chemokines_as_mediators_of_angiogenesis/links/564c877608aeab8ed5e9f0ad.pdf?inViewer=0&pdfJsDownload=0&origin=publication_detail
    [4] Nesbit M, Schaider H, Miller TH, et al. Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells[J]. J Immunol, 2001, 166 (11):6483-6490. doi: 10.4049/jimmunol.166.11.6483
    [5] Allavena P, Sica A, Vecchi A, et al. The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues [J]. Immunol Rev, 2000, 177(1):141-149. doi: 10.1034/j.1600-065X.2000.17714.x
    [6] Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm[J]. Nat Immunol, 2010, 11 (10):889-896. doi: 10.1038/ni.1937
    [7] Staff PO. Correction: a novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cells[J]. PloS One, 2015, 10(1):e0117629. doi: 10.1371/journal.pone.0117629
    [8] Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins[J]. Blood, 1993, 81 (6):1607-1613. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.322.2404&rep=rep1&type=pdf
    [9] David S, Manuel G, Fernando V, et al. CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis[J]. J Clin Invest, 2003, 112(6): 872-882. doi: 10.1172/JCI200319112
    [10] David S, Manuel G, Francisco SM. CD69 is an immunoregulatory molecule induced following activation[J]. Trends Immunol, 2005, 26(3): 136-140. doi: 10.1016/j.it.2004.12.006
    [11] Wang H, Wang X, Li X, et al. CD68(+)HLA-DR(+) M1-like macrophages promote motility of HCC cells via NF-kappaB/FAK pathway[J]. Cancer Lett, 2014, 345(1):91-99. doi: 10.1016/j.canlet.2013.11.013
    [12] Sugimura K, Miyata H, Tanaka K, et al. High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer[J]. J Surg Oncol, 2015, 111(6): 752-759. doi: 10.1002/jso.23881
    [13] Wang H, Li P, Wang L, et al. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type[J]. Ann Hematol, 2015, 94(9):1535-1544. doi: 10.1007/s00277-015-2401-4
    [14] Schaer DJ, Boretti FS, Hongegger A, et al. Molecular cloning and characterization of the mouse CD163 homologue, a highly glucocorticoid-inducible member of the scavenger receptor cysteine-rich family[J]. Immunogenetics, 2001, 53(2):170-177. doi: 10.1007/s002510100304
    [15] Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway[J]. Nat Med, 2000, 6(4):422-428. doi: 10.1038/74680
    [16] Liu Y, Fan L, Wang Y, et al. Tumor-associated macrophages promote tumor cell proliferation in nasopharyngeal NK/T-cell lymphoma[J]. Int J Clin Exp Pathol, 2014, 7(9):5429-5435. http://www.ncbi.nlm.nih.gov/pubmed/25337185
    [17] Behnes CL, Bremmer F, Hemmerlein B, et al. Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma[J]. Virchows Arch, 2014, 464(2):191-196. doi: 10.1007/s00428-013-1523-0
    [18] Józefowski S, Kobzik L. Scavenger receptor A mediates H2O2 production and suppression of IL-12 release in murine macrophages[J]. J Leukoc Biol, 2004, 76(5):1066-1074. doi: 10.1189/jlb.0504270
    [19] Shigeoka M, Urakawa N, Nakamura T, et al. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma[J]. Cancer Sci, 2013, 104(8):1112-1119. doi: 10.1111/cas.12188
    [20] Wang B, Liu H, Dong X, et al. High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder[J]. Oncotarget, 2015, 6(24):20204-20214. https://www.researchgate.net/publication/318882483_Tumor-associated_microgliamacrophages_predict_poor_prognosis_in_high-grade_gliomas_and_correlate_with_an_aggressive_tumor_subtype
    [21] 陈静琦, 曾波航, 朱必胜, 等.乳腺癌细胞表面受体与CCL18结合促进肿瘤迁移的实验[J].肿瘤防治研究, 2014, 41(2): 134-137. http://www.cnki.com.cn/Article/CJFDTOTAL-ZLFY201402010.htm
    [22] 韩洁, 李舜颖, 李倩, 等. IL-4激活的巨噬细胞通过分泌CCL18促进Hela细胞侵袭和迁移[J].中山大学学报(医学科学版), 2017, 38(1): 49-55. http://cdmd.cnki.com.cn/Article/CDMD-90023-2009194697.htm
    [23] 王睿黎, 张婷, 马政文, 等.凝血因子Ⅻ诱导外周血单核细胞分化为卵巢癌腹膜内肿瘤相关巨噬细胞的实验研究[J].现代妇产科进展, 2010, 19(4): 270-273. http://www.cnki.com.cn/Article/CJFDTotal-XDFC201004010.htm
    [24] 陈礼文, 周强, 仲飞, 等. CCL18在非小细胞肺癌患者血清和胸腔积液中的表达及其对外周血单核细胞向树突状细胞分化的调控作用[J].中华肿瘤杂志, 2014, 36(11): 823-827. doi: 10.3760/cma.j.issn.0253-3766.2014.11.005
    [25] Ohnishi K, Komohara Y, Saito Y, et al. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma[J]. Cancer Sci, 2013, 104(9):1237-1244. doi: 10.1111/cas.12212
    [26] Komohara Y, Ohnishi K, Takeya M. Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses [J]. Cancer Sci, 2017, 108(3):290-295. doi: 10.1111/cas.13137
    [27] Zhang Y, Li JQ, Jiang ZZ, et al. CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma[J]. J Pathol, 2016, 239(2):231-241. doi: 10.1002/path.4720
    [28] Shiota T, Miyasato Y, Ohnishi K, et al. The clinical significance of CD169-positive lymph node macrophage in patients with breast cancer[J]. PloS One, 2016, 11(11):e0166680. doi: 10.1371/journal.pone.0166680
    [29] Colegio OR, Chu NQ, Szabo AL, et al. Functional polarization of tumourassociated macrophages by tumour-derived lactic acid[J]. Nature, 2014, 513(7519):559-563. doi: 10.1038/nature13490
    [30] Chen X, Wang Q, Shen Y, et al. Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma[J]. Thyroid, 2012, 22(9):905-910. doi: 10.1089/thy.2011.0452
    [31] 章必成, 赵勇, 王俊, 等.人肺腺癌肿瘤相关巨噬细胞的活化表型鉴定[J].武汉大学学报(医学版), 2009, 30(5): 595-598. http://cpfd.cnki.com.cn/Article/CPFDTOTAL-HJYB200809002A3J.htm
    [32] Omatsu M, Kunimura T, Mikogami T, et al. Difference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumors[J]. Diagn Pathol, 2014, 9:215. doi: 10.1186/s13000-014-0215-7
    [33] Maeda R, Ishii G, Neri S, et al. Circulating CD14+CD204+ cells predict postoperative recurrence in non-small-cell lung cancer patients[J]. J Thorac Oncol, 2014, 9(2):179-188. doi: 10.1097/JTO.0000000000000044
    [34] Wu AC, He Y, Broomfield A, et al. CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer[J]. J Pathol, 2016, 239(2):218-230. doi: 10.1002/path.4718
    [35] Hagemann T, Lawrence T, Mcneish I, et al. "Re-educating" tumor-associated macrophages by targeting NF-κB[J]. J Exp Med, 2008, 205(6): 1261-1268. doi: 10.1084/jem.20080108
    [36] Rolny C, Mazzone M, Tugues S, et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF[J]. Cancer Cell, 2011, 19(1):31-44. doi: 10.1016/j.ccr.2010.11.009
  • 加载中
表(2)
计量
  • 文章访问数:  133
  • HTML全文浏览量:  6
  • PDF下载量:  3
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-11-09
  • 修回日期:  2018-05-02
  • 刊出日期:  2018-05-15

目录

    /

    返回文章
    返回